Cite
26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study
MLA
Jianlu Bi, et al. “26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study.” Diabetes, vol. 69, June 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1ead1b0aecab1892a184a3ff9725f389&authtype=sso&custid=ns315887.
APA
Jianlu Bi, Xianyu Tang, Wei Mo, Shuyue Sheng, Jimin Li, Huijie Zhang, Meiping Guan, Yaoming Xue, Xiangyu Wang, Mengchen Zou, Jiali He, Ping Li, Gugen Xu, & Qian Zhang. (2020). 26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study. Diabetes, 69.
Chicago
Jianlu Bi, Xianyu Tang, Wei Mo, Shuyue Sheng, Jimin Li, Huijie Zhang, Meiping Guan, et al. 2020. “26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study.” Diabetes 69 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1ead1b0aecab1892a184a3ff9725f389&authtype=sso&custid=ns315887.